Zizi Petkova

• Mubadala Capital-TWG Global-led consortium on its pending $6.2 billion acquisition of Clear Channel Outdoor.
• Terns Pharmaceuticals on its $6.7 billion acquisition by Merck.
• Merck KGaA on its acquisition of the chromatography business of JSR Life Sciences.
• Allwyn International AG on its acquisition of a majority stake in PrizePicks for an enterprise value of up to $4.15 billion.
• Triumph Group Inc. on a variety of transactions, including its:
  • $3 billion sale to Warburg Pincus and Berkshire Partners,
  • $725 million sale of its Product Support business to AAR CORP.,
  • settlement with activist stockholder Vision One Management Partners, LP and
  • sale of operations and assets relating to its Global 7500 wing manufacturing program to Bombardier.
• The special committee of R1 RCM Inc. on its $8.9 billion sale to investment funds affiliated with TowerBrook Capital Partners and Clayton Dubilier & Rice.
• Reliance Industries Limited on its $8.5 billion joint venture with The Walt Disney Company and Viacom 18 Media Private Limited to merge their respective digital streaming and television assets in India.
• Kaman Corporation on a variety of transactions, including its:
  • $1.8 billion sale to Arcline Investment Management,
  • strategic business partnership with PHI Aviation LLC,
  • investment in, and strategic business partnership with, Near Earth Autonomy, Inc. and
  • $330 million acquisition of Bal Seal Engineering, Inc.
• TriRx Pharmaceuticals, LLC on its sale of its manufacturing site and operations in Shawnee, Kansas to Argenta Pharmaceutical Services.
• The special committee of P&F Industries Inc. on its sale to ShoreView Industries LLC.
• JPMorgan Chase & Co. in connection with its relationship with Visa Inc. in the restructuring of Visa’s capital structure.
• GX Acquisition Corp. II on its $313.5 million initial business combination with NioCorp Developments Ltd.
• Mars, Incorporated on its:
  • acquisition of Champion Petfoods, and
  • reorganization to combine its chocolate and Wrigley segments to create Mars Wrigley Confectionery.
• Openlane, Inc. on its:
  • $2.2 billion sale of its ADESA U.S. physical auction business to Carvana, and
  • spin-off of IAA, Inc., its salvage auction vehicle business.
• Danaher Corporation on its:
  • acquisition of Nature Technology Corporation, and
  • acquisition of Intabio, Inc.
• VYNE Therapeutics, Inc. on the sale of its Molecule Stabilizing Technology franchise to Journey Medical Corporation.
• Osprey Technology Acquisition Corp. on its $1.1 billion initial business combination with BlackSky Holdings, Inc.
• Perella Weinberg Partners on its $975 million business combination with FinTech Acquisition Corp. IV (sponsored by Betsy and Daniel Cohen).
• Kelso & Company in its investment in Foundation Consumer Brands in connection with the acquisition of seven brands, including Breathe Right Nasal Strips, from GSK Consumer Healthcare.
• Norwest Equity Partners on its acquisition of Clover Imaging Group.
• Coty Inc. on its $600 million acquisition of a controlling stake in Kylie Jenner’s cosmetics business.
• Quadion LLC (d/b/a Minnesota Rubber and Plastics), a portfolio company of Norwest Equity Partners, on its acquisition by Kohlberg Kravis Roberts & Co. LP.
• Veritas Capital on its $700 million acquisition of the capital services business of Chicago Bridge & Iron Company N.V.

*This list includes work that Zizi completed while at a prior firm.